Attenuated Novel SARS Coronavirus 2 Infection in an Allogeneic Hematopoietic Stem Cell Transplant patient on Ruxolitinib
Publication date: Available online 25 June 2020Source: Clinical Lymphoma Myeloma and LeukemiaAuthor(s): Francine M. Foss, Ami Rubinowitz, Marie L. Landry, Iris Isufi, Lohith Gowda, Stuart Seropian, Sarah Perreault, Sheela V. Shenoi
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
More News: Cancer & Oncology | Coronavirus | COVID-19 | Leukemia | Lymphoma | Myeloma | SARS | Stem Cell Therapy | Stem Cells | Transplants